Annovis Bio Enrolls Over 850 Patients for Its Next Alzheimer's Disease Trial

Trial StartPositive

AI Analysis

Summary

Annovis Bio has enrolled over 850 patients for its next Alzheimer's Disease trial. The announcement indicates progress in trial recruitment without providing specific drug name, phase, or timeline details.

Clinical Trial Data

Patients

850

Importance:3/10

Sentiment:

0.50

Alzheimer's DiseaseClinical TrialPatient Enrollment

Related Companies

$ANVS

Read the original article

Published by yahoo_finance on July 7, 2026 2:51 PM

Read Original